These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6521215)

  • 41. Hemodynamic effects of cutaneously administered isosorbide dinitrate ointment.
    Schinz A; Schnelle K; Klein G
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):297-301. PubMed ID: 669875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemodynamic changes associated with angina pectoris induced by maximal treadmill exercise: effect of sublingual isosorbide dinitrate on systolic time intervals.
    Thompson EJ; Glass P; Ansari A; Arora J
    Angiology; 1976 May; 27(5):269-79. PubMed ID: 1053551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic assessment of intravenous Isosorbidi Dinitras in coronary heart disease.
    Qi WH; Qian F
    Chin Med J (Engl); 1992 Feb; 105(2):159-62. PubMed ID: 1597078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Nitrosorbide in the treatment of cardiac insufficiency in patients with ischemic heart disease].
    Kupchinskaia EG
    Vrach Delo; 1983 Jan; (1):21-3. PubMed ID: 6868491
    [No Abstract]   [Full Text] [Related]  

  • 45. [Long-term effect of a new delayed-action nitroglycerin compared to isosorbide dinitrate. Double-blind hemodynamic study].
    Witt E; Lehmann HU; Traue P; Hochrein H
    Dtsch Med Wochenschr; 1983 Feb; 108(6):216-20. PubMed ID: 6402355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cardiac output and central-hemodynamic parameter under bencyclan (author's transl)].
    Heidrich H; Paeprer H; Schneider B
    Z Kardiol; 1979 Jan; 68(1):53-6. PubMed ID: 419810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Intravenous administration of dianhydro-sorbitol dinitrate in the low cardiac output syndrome after heart surgery].
    Fortuna AB; Wada L; Baccarin V; Hatsumura M; Lima CE; Vieira RW
    Arq Bras Cardiol; 1979 Feb; 32(2):81-6. PubMed ID: 464856
    [No Abstract]   [Full Text] [Related]  

  • 48. Management of acute heart failure following myocardial infarction: hemodynamic advantages of isosorbide dinitrate over frusemide.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Z Kardiol; 1983; 72 Suppl 3():141-6. PubMed ID: 6666215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
    Smolarz A; Seeliger S; Glocke M
    Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effects of sublingual isosorbide dinitrate on systolic time intervals in normal subjects and those with coronary disease].
    Paterna S; Campisi D; Bivona A; Valenza M; Di Maso N; Alaimo V
    Boll Soc Ital Biol Sper; 1984 Jan; 60(1):29-35. PubMed ID: 6704251
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of prostaglandin Bl on systemic and regional hemodynamics].
    Ismailov ShI; Flerov EV
    Biull Eksp Biol Med; 1977 Feb; 83(2):131-3. PubMed ID: 851612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of ouabain on myocardial oxygen supply and demand in patients with chronic coronary artery disease. A hemodynamic, volumetric, and metabolic study in patients without heart failure.
    DeMots H; Rahimtoola SH; Kremkau EL; Bennett W; Mahler D
    J Clin Invest; 1976 Aug; 58(2):312-9. PubMed ID: 783197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Influence of isosorbiddinitrate on hemodynamics at rest and during exercise (author's transl)].
    Spiel R; Dittel M; Kiss E; Nobis H; Prachar H; Spiel C; Enenkel W
    Z Kardiol; 1980 Jun; 69(6):444-51. PubMed ID: 7445646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemodynamic effects of carbochromen.
    Barletta GA; Malfanti PL; Bisi G; Franchi F; Fantini F
    Acta Cardiol; 1982; 37(5):305-12. PubMed ID: 6983802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hemodynamic and electrocardiographic prolonged nitrate effect during frequency load in coronary disease].
    Wolf R; Beck OA; Guhl E; Hochrein H
    Z Kardiol; 1976 May; 65(5):435-44. PubMed ID: 820104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic and coronary vascular effects of the 2- and the 5-mononitrate esters of isosorbide.
    Wendt RL
    J Pharmacol Exp Ther; 1972 Mar; 180(3):732-42. PubMed ID: 4622308
    [No Abstract]   [Full Text] [Related]  

  • 57. Hemodynamic aspects of the treatment of ischemic heart disease.
    Wellens D
    Angiology; 1977 Dec; 28(12):839-43. PubMed ID: 23714
    [No Abstract]   [Full Text] [Related]  

  • 58. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Predicting the effectiveness of nitrosorbide with regard to increasing tolerance to physical loads].
    Sledzevskaia IK; Il'iash MG
    Ter Arkh; 1986; 58(5):85-7. PubMed ID: 3526616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of isosorbide dinitrate in relation to posture and age].
    Westermann KW; Bischoff K; Kugler G; Schnabel A
    Z Kardiol; 1976 Dec; 65(12):1060-70. PubMed ID: 1014800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.